Kahn Brothers Kahn Brothers Group
Kahn Brothers Group is a value investment firm founded in the tradition of Benjamin Graham and long associated with the Kahn family of investors. The firm is known for deep-value security analysis, patience, and a multi-decade orientation to intrinsic value. Its filings are followed by classic value investors seeking Graham-and-Dodd style managers still active in public markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$4.05M |
| 2 |
GSK
GSK
|
+$3.55M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$2.81M |
| 4 |
VRAY
ViewRay, Inc.
VRAY
|
+$2.17M |
| 5 |
Pfizer
PFE
|
+$1.83M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BlackBerry
BB
|
+$1.76M |
| 2 |
BP
BP
|
+$1.12M |
| 3 |
Rafael Holdings
RFL
|
+$392K |
| 4 |
HOLX
Hologic
HOLX
|
+$226K |
| 5 |
Seaboard Corp
SEB
|
+$119K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 37.69% |
| 2 | Healthcare | 34.09% |
| 3 | Energy | 15.29% |
| 4 | Consumer Staples | 5.48% |
| 5 | Technology | 3.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
MBIA
MBI
$250M
| $78.6M | 10.8% |
4,978,900
+11,067
| +0.2% | +$146K |
|
2
Assured Guaranty
AGO
$3.27B
| $72.1M | 9.9% |
1,435,845
+3,420
| +0.2% | +$176K |
|
|
3
GSK
GSK
$105B
| $63.4M | 8.71% |
1,150,855
+68,169
| +6% | +$3.55M |
|
|
4
Pfizer
PFE
$160B
| $60.1M | 8.26% |
1,017,928
+36,940
| +4% | +$1.83M |
|
|
5
BP
BP
$115B
| $59.7M | 8.2% |
2,240,889
-40,545
| -2% | -$1.12M |
|
|
FLG
6
Flagstar Bank National Association
FLG
$5.59B
| $59.6M | 8.18% |
1,625,880
+27,756
| +2% | +$1.06M |
|
|
7
Bristol-Myers Squibb
BMY
$137B
| $57.5M | 7.89% |
921,603
+47,873
| +5% | +$2.81M |
|
8
Merck
MRK
$376B
| $54.4M | 7.47% |
709,224
+3,041
| +0.4% | +$242K |
|
|
9
Citigroup
C
$221B
| $54M | 7.41% |
893,788
+60,852
| +7% | +$4.05M |
|
10
Patterson-UTI
PTEN
$4.71B
| $50.3M | 6.91% |
5,956,377
-1,987
| -0% | -$17.1K |
|
|
11
Seaboard Corp
SEB
$4.08B
| $39.5M | 5.43% |
10,048
-30
| -0.3% | -$119K |
|
|
VOXX
12
DELISTED
VOXX International Corporation Class A
VOXX
| $20.6M | 2.83% |
2,023,059
+69,749
| +4% | +$776K |
|
|
STL
13
DELISTED
Sterling Bancorp
STL
| $6.98M | 0.96% |
270,498
-2,521
| -0.9% | -$65.2K |
|
|
VRAY
14
DELISTED
ViewRay, Inc.
VRAY
| $5.07M | 0.7% |
920,200
+357,045
| +63% | +$2.17M |
|
|
TPHS
15
DELISTED
Trinity Place Holdings Inc.com
TPHS
| $2.71M | 0.37% |
1,473,462
+121,163
| +9% | +$237K |
|
|
HOLX
16
DELISTED
Hologic
HOLX
| $2.49M | 0.34% |
32,539
-3,080
| -9% | -$226K |
|
17
Organon & Co
OGN
$3.61B
| $2.1M | 0.29% |
68,870
-1,294
| -2% | -$42.1K |
|
18
Novartis
NVS
$302B
| $1.96M | 0.27% |
22,378
+1,980
| +10% | +$164K |
|
|
19
BlackBerry
BB
$4.71B
| $1.44M | 0.2% |
1,543,947
-175,570
| -10% | -$1.76M |
|
|
20
Rafael Holdings
RFL
$112M
| $1.44M | 0.2% |
286,969
-29,130
| -9% | -$392K |
|
21
Viatris
VTRS
$18.7B
| $1.19M | 0.16% |
88,280
+188
| +0.2% | +$2.51K |
|
22
Zedge
ZDGE
$38M
| $1.07M | 0.15% |
123,179
+834
| +0.7% | +$9.14K |
|
23
Berkshire Hathaway Class B
BRK.B
$1.06T
| $972K | 0.13% |
3,250
| – | – |
|
24
ExxonMobil
XOM
$679B
| $952K | 0.13% |
15,564
| – | – |
|
25
Verizon
VZ
$205B
| $816K | 0.11% |
15,714
-550
| -3% | -$28.7K |
|
Similar funds
Kahn Brothers's Q4 2021 Portfolio in Review
As of Q4 2021, Kahn Brothers held 43 positions worth $728M, up 2.5% from $710M the previous quarter. Its ten largest holdings account for 84% of the portfolio.
Trading was light in Q4 2021: portfolio turnover was 0%. Kahn Brothers opened no new positions and made no exits, leaving the 43-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 38% of assets, up from 37% a quarter earlier, followed by Healthcare and Energy.
- Kahn Brothers added most to Citigroup in Q4 2021, an estimated $4.05M increase.
- Kahn Brothers's biggest Q4 2021 reduction was BlackBerry, cutting an estimated $1.76M.
- Kahn Brothers's ten largest holdings make up 84% of its $728M portfolio in Q4 2021.
- Kahn Brothers opened 0 new positions and closed 0 in Q4 2021.
- Kahn Brothers's portfolio value rose 2.5% quarter-over-quarter to $728M.
Based on Kahn Brothers Group's 13F filing for Q4 2021, filed 25 Jan 2022.